Loxo

1 result

Loxo is developing cancer treatments that target a tumors’ genetic markers regardless of where in the body they’re located

US pharma giant Eli Lilly is to buy Loxo Oncology for about $8 billion (€7 billion) in cash, the second multibillion-dollar cancer deal of the year by(...)